IOVANCE BIOTHERAPEUTICS, INC. Operating Income
IOVANCE BIOTHERAPEUTICS, INC. (IOVA) reported Operating Income of -$51.91 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- IOVANCE BIOTHERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-06-30 was -$51.91M.
- IOVANCE BIOTHERAPEUTICS, INC. operating income (loss) for the quarter ending 2026-03-31 was -$81.04M.
- IOVANCE BIOTHERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-12-31 was -$73.46M.
- IOVANCE BIOTHERAPEUTICS, INC. operating income (loss) for the quarter ending 2025-09-30 was -$94.90M.
- IOVANCE BIOTHERAPEUTICS, INC. operating income (loss) for fiscal 2025 was -$403.36M.
- IOVANCE BIOTHERAPEUTICS, INC. operating income (loss) for fiscal 2024 was -$395.28M.
- IOVANCE BIOTHERAPEUTICS, INC. operating income (loss) for fiscal 2023 was -$460.56M.
- IOVANCE BIOTHERAPEUTICS, INC. operating income (loss) for fiscal 2022 was -$398.88M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 6 month | Operating Income (Loss) 6 month as first filed | Operating Income (Loss) 9 month | Operating Income (Loss) 9 month as first filed | Operating Income (Loss) 12 month | Operating Income (Loss) 12 month as first filed | Operating Income (Loss) 45 month | Operating Income (Loss) 48 month | Operating Income (Loss) 51 month | Operating Income (Loss) 54 month | Operating Income (Loss) 57 month | Operating Income (Loss) 60 month | Operating Income (Loss) 63 month | Operating Income (Loss) 66 month | Operating Income (Loss) 69 month | Operating Income (Loss) 72 month | Operating Income (Loss) 78 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$51.91M 10-Q · filed 2026-08-06 | -$132.95M 10-Q · filed 2026-08-06 | -$206.41M derived: sum of 3 quarters · filed 2026-08-06 | -$301.31M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||||
| 2026-03-31 | -$81.04M 10-Q · filed 2026-05-07 | -$154.50M derived: sum of 2 quarters · filed 2026-05-07 | -$249.40M derived: sum of 3 quarters · filed 2026-05-07 | -$363.18M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||||
| 2025-12-31 | -$73.46M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$168.36M derived: sum of 2 quarters · filed 2026-02-24 | -$282.13M derived: sum of 3 quarters · filed 2026-08-06 | -$403.36M 10-K · filed 2026-02-24 | |||||||||||||||
| 2025-09-30 | -$94.90M 10-Q · filed 2025-11-06 | -$208.68M derived: sum of 2 quarters · filed 2026-08-06 | -$329.90M 10-Q · filed 2025-11-06 | -$416.47M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||||
| 2025-06-30 | -$113.77M 10-Q · filed 2026-08-06 | -$235.00M 10-Q · filed 2026-08-06 | -$321.57M derived: sum of 3 quarters · filed 2026-08-06 | -$410.64M derived: sum of 4 quarters · filed 2026-08-06 | |||||||||||||||
| 2025-03-31 | -$121.22M 10-Q · filed 2026-05-07 | -$207.80M derived: sum of 2 quarters · filed 2026-05-07 | -$296.86M derived: sum of 3 quarters · filed 2026-05-07 | -$398.78M derived: sum of 4 quarters · filed 2026-05-07 | |||||||||||||||
| 2024-12-31 | -$86.58M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$175.64M derived: sum of 2 quarters · filed 2026-02-24 | -$277.56M derived: sum of 3 quarters · filed 2026-02-24 | -$395.28M 10-K · filed 2026-02-24 | |||||||||||||||
| 2024-09-30 | -$89.07M 10-Q · filed 2025-11-06 | -$190.98M derived: sum of 2 quarters · filed 2025-11-06 | -$308.70M 10-Q · filed 2025-11-06 | -$429.96M derived: sum of 4 quarters · filed 2026-02-24 | |||||||||||||||
| 2024-06-30 | -$101.91M 10-Q · filed 2025-08-07 | -$219.64M 10-Q · filed 2025-08-07 | -$340.89M derived: sum of 3 quarters · filed 2026-02-24 | -$459.25M derived: sum of 4 quarters · filed 2026-02-24 | |||||||||||||||
| 2024-03-31 | -$117.72M 10-Q · filed 2025-05-08 | -$238.98M derived: sum of 2 quarters · filed 2026-02-24 | -$357.34M derived: sum of 3 quarters · filed 2026-02-24 | -$467.43M derived: sum of 4 quarters · filed 2026-02-24 | |||||||||||||||
| 2023-12-31 | -$121.26M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$239.62M derived: sum of 2 quarters · filed 2026-02-24 | -$349.70M derived: sum of 3 quarters · filed 2026-02-24 | -$460.56M 10-K · filed 2026-02-24 | |||||||||||||||
| 2023-09-30 | -$118.36M 10-Q · filed 2024-11-07 | -$228.45M derived: sum of 2 quarters · filed 2024-11-07 | -$339.30M 10-Q · filed 2024-11-07 | -$446.34M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||||
| 2023-06-30 | -$110.09M 10-Q · filed 2024-08-08 | -$220.94M 10-Q · filed 2024-08-08 | -$327.98M derived: sum of 3 quarters · filed 2025-02-27 | -$428.37M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||||
| 2023-03-31 | -$110.86M 10-Q · filed 2024-05-09 | -$217.89M derived: sum of 2 quarters · filed 2025-02-27 | -$318.29M derived: sum of 3 quarters · filed 2025-02-27 | -$418.02M derived: sum of 4 quarters · filed 2025-02-27 | |||||||||||||||
| 2022-12-31 | -$107.04M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$207.43M derived: sum of 2 quarters · filed 2025-02-27 | -$307.17M derived: sum of 3 quarters · filed 2025-02-27 | -$398.88M 10-K · filed 2025-02-27 | |||||||||||||||
| 2022-09-30 | -$100.39M 10-Q · filed 2023-11-07 | -$200.13M derived: sum of 2 quarters · filed 2023-11-07 | -$291.84M 10-Q · filed 2023-11-07 | -$391.31M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||||||
| 2022-06-30 | -$99.73M 10-Q · filed 2023-08-08 | -$191.45M 10-Q · filed 2023-08-08 | -$290.91M derived: sum of 3 quarters · filed 2024-02-28 | -$377.15M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||||||
| 2022-03-31 | -$91.71M 10-Q · filed 2023-05-10 | -$191.18M derived: sum of 2 quarters · filed 2024-02-28 | -$277.42M derived: sum of 3 quarters · filed 2024-02-28 | -$358.85M derived: sum of 4 quarters · filed 2024-02-28 | |||||||||||||||
| 2021-12-31 | -$99.47M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | -$185.71M derived: sum of 2 quarters · filed 2024-02-28 | -$267.13M derived: sum of 3 quarters · filed 2024-02-28 | -$342.70M 10-K · filed 2024-02-28 | |||||||||||||||
| 2021-09-30 | -$86.24M 10-Q · filed 2022-11-03 | -$167.67M derived: sum of 2 quarters · filed 2022-11-03 | -$243.24M 10-Q · filed 2022-11-03 | -$311.77M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||||||
| 2021-06-30 | -$81.43M 10-Q · filed 2022-08-04 | -$157.00M 10-Q · filed 2022-08-04 | -$225.53M derived: sum of 3 quarters · filed 2023-02-28 | -$284.50M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||||||
| 2021-03-31 | -$75.57M 10-Q · filed 2022-05-05 | -$144.10M derived: sum of 2 quarters · filed 2023-02-28 | -$203.07M derived: sum of 3 quarters · filed 2023-02-28 | -$266.70M derived: sum of 4 quarters · filed 2023-02-28 | |||||||||||||||
| 2020-12-31 | -$68.53M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$127.50M derived: sum of 2 quarters · filed 2023-02-28 | -$191.13M derived: sum of 3 quarters · filed 2023-02-28 | -$261.94M 10-K · filed 2023-02-28 | |||||||||||||||
| 2020-09-30 | -$58.97M 10-Q · filed 2021-11-04 | -$122.59M derived: sum of 2 quarters · filed 2021-11-04 | -$193.40M 10-Q · filed 2021-11-04 | -$258.51M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||||||||
| 2020-06-30 | -$63.63M 10-Q · filed 2021-08-05 | -$134.44M 10-Q · filed 2021-08-05 | -$199.55M derived: sum of 3 quarters · filed 2022-02-24 | -$251.16M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||||||||
| 2020-03-31 | -$70.81M 10-Q · filed 2021-05-06 | -$135.92M derived: sum of 2 quarters · filed 2022-02-24 | -$187.53M derived: sum of 3 quarters · filed 2022-02-24 | -$237.70M derived: sum of 4 quarters · filed 2022-02-24 | |||||||||||||||
| 2019-12-31 | -$65.11M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | -$116.72M derived: sum of 2 quarters · filed 2022-02-24 | -$166.89M derived: sum of 3 quarters · filed 2022-02-24 | -$206.87M 10-K · filed 2022-02-24 | |||||||||||||||
| 2019-09-30 | -$51.61M 10-Q · filed 2020-11-05 | -$101.78M derived: sum of 2 quarters · filed 2020-11-05 | -$141.76M 10-Q · filed 2020-11-05 | -$176.71M derived: sum of 4 quarters · filed 2021-02-25 | |||||||||||||||
| 2019-06-30 | -$50.16M 10-Q · filed 2020-08-06 | -$90.15M 10-Q · filed 2020-08-06 | -$125.09M derived: sum of 3 quarters · filed 2021-02-25 | -$160.15M derived: sum of 4 quarters · filed 2021-02-25 | |||||||||||||||
| 2019-03-31 | -$39.99M 10-Q · filed 2020-05-05 | -$74.93M derived: sum of 2 quarters · filed 2021-02-25 | -$109.99M derived: sum of 3 quarters · filed 2021-02-25 | -$141.37M derived: sum of 4 quarters · filed 2021-02-25 | |||||||||||||||
| 2018-12-31 | -$34.94M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | -$70.00M derived: sum of 2 quarters · filed 2021-02-25 | -$101.38M derived: sum of 3 quarters · filed 2021-02-25 | -$128.26M 10-K · filed 2021-02-25 | |||||||||||||||
| 2018-09-30 | -$35.06M 10-Q · filed 2019-11-04 | -$66.44M derived: sum of 2 quarters · filed 2019-11-04 | -$93.31M 10-Q · filed 2019-11-04 | -$119.39M derived: sum of 4 quarters · filed 2020-02-25 | |||||||||||||||
| 2018-06-30 | -$31.38M 10-Q · filed 2019-08-01 | -$58.26M 10-Q · filed 2019-08-01 | -$84.33M derived: sum of 3 quarters · filed 2020-02-25 | -$106.67M derived: sum of 4 quarters · filed 2020-02-25 | |||||||||||||||
| 2018-03-31 | -$26.88M 10-Q · filed 2019-05-07 | -$52.95M derived: sum of 2 quarters · filed 2020-02-25 | -$75.29M derived: sum of 3 quarters · filed 2020-02-25 | -$98.87M derived: sum of 4 quarters · filed 2020-02-25 | |||||||||||||||
| 2017-12-31 | -$26.07M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | -$48.41M derived: sum of 2 quarters · filed 2020-02-25 | -$72.00M derived: sum of 3 quarters · filed 2020-02-25 | -$92.88M 10-K · filed 2020-02-25 | |||||||||||||||
| 2017-09-30 | -$22.34M 10-Q · filed 2018-11-06 | -$45.92M derived: sum of 2 quarters · filed 2018-11-06 | -$66.81M 10-Q · filed 2018-11-06 | -$82.73M derived: sum of 4 quarters · filed 2019-02-28 | |||||||||||||||
| 2017-06-30 | -$23.58M 10-Q · filed 2018-08-07 | -$44.46M 10-Q · filed 2018-08-07 | -$60.38M derived: sum of 3 quarters · filed 2019-02-28 | -$79.36M derived: sum of 4 quarters · filed 2019-02-28 | |||||||||||||||
| 2017-03-31 | -$20.88M 10-Q · filed 2018-05-10 | -$36.80M derived: sum of 2 quarters · filed 2019-02-28 | -$55.78M derived: sum of 3 quarters · filed 2019-02-28 | -$67.51M derived: sum of 4 quarters · filed 2019-02-28 | |||||||||||||||
| 2016-12-31 | -$15.92M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-28 | -$34.90M derived: sum of 2 quarters · filed 2019-02-28 | -$46.63M derived: sum of 3 quarters · filed 2019-02-28 | -$53.64M 10-K · filed 2019-02-28 | |||||||||||||||
| 2016-09-30 | -$18.98M 10-Q · filed 2017-11-02 | -$30.71M derived: sum of 2 quarters · filed 2017-11-02 | -$37.72M 10-Q · filed 2017-11-02 | -$46.20M derived: sum of 4 quarters · filed 2018-03-12 | |||||||||||||||
| 2016-06-30 | -$11.73M 10-Q · filed 2017-08-03 | -$18.74M 10-Q · filed 2017-08-03 | -$27.22M derived: sum of 3 quarters · filed 2018-03-12 | -$34.86M derived: sum of 4 quarters · filed 2018-03-12 | |||||||||||||||
| 2016-03-31 | -$7.01M 10-Q · filed 2017-05-03 | -$15.49M derived: sum of 2 quarters · filed 2018-03-12 | -$23.13M derived: sum of 3 quarters · filed 2018-03-12 | -$29.57M derived: sum of 4 quarters · filed 2018-03-12 | |||||||||||||||
| 2015-12-31 | -$8.48M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12 | -$16.12M derived: sum of 2 quarters · filed 2018-03-12 | -$22.56M derived: sum of 3 quarters · filed 2018-03-12 | -$27.86M 10-K · filed 2018-03-12 | |||||||||||||||
| 2015-09-30 | -$7.64M 10-Q · filed 2016-11-04 | -$14.08M derived: sum of 2 quarters · filed 2016-11-04 | -$19.38M 10-Q · filed 2016-11-04 | -$19.41M 10-Q · filed 2015-11-06 | -$24.25M derived: sum of 4 quarters · filed 2017-03-09 | ||||||||||||||
| 2015-06-30 | -$6.44M 10-Q · filed 2016-08-09 | -$6.44M 10-Q · filed 2015-08-10 | -$11.74M 10-Q · filed 2016-08-09 | -$11.74M 10-Q · filed 2015-08-10 | -$16.61M derived: sum of 3 quarters · filed 2017-03-09 | -$19.41M derived: sum of 4 quarters · filed 2017-03-09 | |||||||||||||
| 2015-03-31 | -$5.30M 10-Q · filed 2016-05-09 | -$10.17M derived: sum of 2 quarters · filed 2017-03-09 | -$12.97M derived: sum of 3 quarters · filed 2017-03-09 | -$15.08M derived: sum of 4 quarters · filed 2017-03-09 | |||||||||||||||
| 2014-12-31 | -$4.87M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-09 | -$7.67M derived: sum of 2 quarters · filed 2017-03-09 | -$9.78M derived: sum of 3 quarters · filed 2017-03-09 | -$12.04M 10-K · filed 2017-03-09 | -$12.04M 10-K · filed 2015-03-16 | ||||||||||||||
| 2014-09-30 | -$2.80M 10-Q · filed 2015-11-06 | -$2.80M 10-Q · filed 2014-11-13 | -$4.91M derived: sum of 2 quarters · filed 2015-11-06 | -$7.17M 10-Q · filed 2015-11-06 | -$7.17M 10-Q · filed 2014-11-13 | -$18.67M derived: sum of 4 quarters · filed 2016-03-11 | |||||||||||||
| 2014-06-30 | -$2.11M 10-Q · filed 2015-08-10 | -$4.37M 10-Q · filed 2015-08-10 | -$15.87M derived: sum of 3 quarters · filed 2016-03-11 | -$25.28M derived: sum of 4 quarters · filed 2016-03-11 | |||||||||||||||
| 2014-03-31 | -$2.26M 10-Q · filed 2014-05-14 | -$13.76M derived: sum of 2 quarters · filed 2016-03-11 | -$23.17M derived: sum of 3 quarters · filed 2016-03-11 | -$24.20M derived: sum of 4 quarters · filed 2016-03-11 | -$55.14M 10-Q · filed 2014-05-14 | ||||||||||||||
| 2013-12-31 | -$11.50M derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-11 | -$20.91M derived: sum of 2 quarters · filed 2016-03-11 | -$21.94M derived: sum of 3 quarters · filed 2016-03-11 | -$22.64M 10-K · filed 2016-03-11 | -$22.64M 10-K · filed 2014-03-28 | -$52.88M 10-K · filed 2014-03-28 | |||||||||||||
| 2013-09-30 | -$9.41M 10-Q · filed 2014-11-13 | -$10.44M derived: sum of 2 quarters · filed 2014-11-13 | -$11.14M 10-Q · filed 2014-11-13 | -$12.87M derived: sum of 4 quarters · filed 2014-11-13 | -$41.38M 10-Q · filed 2013-11-14 | ||||||||||||||
| 2013-06-30 | -$1.03M 10-Q · filed 2014-08-08 | -$1.73M 10-Q · filed 2014-08-08 | -$3.46M derived: sum of 3 quarters · filed 2014-08-08 | -$5.08M derived: sum of 4 quarters · filed 2014-08-08 | -$31.98M 10-Q · filed 2013-10-23 | ||||||||||||||
| 2013-03-31 | -$704.91K 10-Q · filed 2014-05-14 | -$2.43M derived: sum of 2 quarters · filed 2014-05-14 | -$4.06M derived: sum of 3 quarters · filed 2014-05-14 | -$5.70M derived: sum of 4 quarters · filed 2014-05-14 | -$30.95M 10-Q · filed 2013-10-23 | ||||||||||||||
| 2012-12-31 | -$1.72M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | -$3.35M derived: sum of 2 quarters · filed 2014-03-28 | -$5.00M derived: sum of 3 quarters · filed 2014-03-28 | -$8.13M 10-K · filed 2014-03-28 | -$30.24M 10-K · filed 2013-09-23 | ||||||||||||||
| 2012-09-30 | -$1.63M 10-Q · filed 2013-11-14 | -$3.27M derived: sum of 2 quarters · filed 2013-11-14 | -$6.41M 10-Q · filed 2013-11-14 | -$10.59M derived: sum of 4 quarters · filed 2013-11-14 | -$28.52M 10-Q · filed 2013-01-25 | ||||||||||||||
| 2012-06-30 | -$1.65M 10-Q · filed 2013-10-23 | -$4.78M 10-Q · filed 2013-10-23 | -$8.97M derived: sum of 3 quarters · filed 2013-10-23 | -$14.78M derived: sum of 4 quarters · filed 2013-10-23 | -$26.89M 10-Q/A · filed 2012-09-10 | ||||||||||||||
| 2012-03-31 | -$3.14M 10-Q · filed 2013-10-23 | -$7.32M derived: sum of 2 quarters · filed 2013-10-23 | -$13.14M derived: sum of 3 quarters · filed 2013-10-23 | -$23.70M derived: sum of 4 quarters · filed 2013-10-23 | -$25.24M 10-Q · filed 2012-05-15 | ||||||||||||||
| 2011-12-31 | -$4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2013-09-23 | -$10.00M derived: sum of 2 quarters · filed 2013-09-23 | -$20.56M derived: sum of 3 quarters · filed 2013-09-23 | -$21.22M 10-K · filed 2013-09-23 | -$22.11M 10-K · filed 2012-03-30 | ||||||||||||||
| 2011-09-30 | -$5.81M 10-Q · filed 2013-01-25 | -$16.38M derived: sum of 2 quarters · filed 2013-01-25 | -$17.03M 10-Q · filed 2013-01-25 | -$17.53M derived: sum of 4 quarters · filed 2013-01-25 | -$17.92M 10-Q · filed 2011-11-21 | ||||||||||||||
| 2011-06-30 | -$10.56M 10-Q/A · filed 2012-09-10 | -$11.22M 10-Q/A · filed 2012-09-10 | -$11.72M derived: sum of 3 quarters · filed 2012-09-10 | -$11.88M derived: sum of 4 quarters · filed 2012-09-10 | -$12.11M 10-Q/A · filed 2011-09-01 | ||||||||||||||
| 2011-03-31 | -$658.25K 10-Q · filed 2012-05-15 | -$1.15M derived: sum of 2 quarters · filed 2012-05-15 | -$1.32M derived: sum of 3 quarters · filed 2012-05-15 | -$1.41M derived: sum of 4 quarters · filed 2012-05-15 | |||||||||||||||
| 2010-12-31 | -$496.08K derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-30 | -$663.10K derived: sum of 2 quarters · filed 2012-03-30 | -$747.73K derived: sum of 3 quarters · filed 2012-03-30 | -$815.41K 10-K · filed 2012-03-30 | |||||||||||||||
| 2010-09-30 | -$167.03K 10-Q · filed 2011-11-21 | -$251.66K derived: sum of 2 quarters · filed 2011-11-21 | -$319.34K 10-Q · filed 2011-11-21 | ||||||||||||||||
| 2010-06-30 | -$84.63K 10-Q/A · filed 2011-09-01 | -$152.31K 10-Q/A · filed 2011-09-01 | |||||||||||||||||
| 2009-12-31 | -$15.77K 10-K · filed 2012-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Adaptive Biotechnologies Corp (ADPT) | United States | $4.719B | -53.43 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 | |
| Relay Therapeutics, Inc. (RLAY) | United States | $3.884B | -14.30 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Tarsus Pharmaceuticals, Inc. (TARS) | United States | $3.329B | -58.60 |
| Denali Therapeutics Inc. (DNLI) | United States | $3.274B | -8.04 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| Beam Therapeutics Inc. (BEAM) | United States | $2.549B | -41.51 |
| Greenland Mines Ltd (GRML) | United States | $2.362B |